stellamune mycoplasma inj. emuls. i.m. flac.
elanco - geïnactiveerd mycoplasma hyopneumoniae min. 6000 ur/dose - emulsie voor injectie - geïnactiveerd mycoplasma hyopneumoniae - mycoplasma - varken
mhyosphere pcv id
laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - varkens - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.
nobilis mycroplasma s flac.
intervet international - levend, mycoplasma synoviae =10exp6,5 en =10exp8,0 cfu-dose - lyofilisaat voor suspensie - levend, geattenueerd mycoplasma synoviae - mycoplasma - pluimvee
plasmalyte 148 + glucose 5 % w/v viaflo inf. opl. i.v.
baxter sa-nv - natriumacetaattrihydraat 3,68 g/l; kaliumchloride 370 µg/ml; magnesiumchloridehexahydraat 300 µg/ml; natriumgluconaat 5,02 mg/ml; natriumchloride 5,26 mg/ml; glucosemonohydraat 55 mg/ml - oplossing voor infusie - glucosemonohydraat 55 mg/ml; magnesiumchloridehexahydraat 300 µg/ml; kaliumchloride 370 µg/ml; natriumgluconaat 5.02 mg/ml; natriumchloride 5.26 mg/ml; natriumacetaattrihydraat - electrolytes with carbohydrates
plasmalyte a viaflo inf. opl. i.v.
baxter sa-nv - natriumacetaattrihydraat 3,68 g/l; kaliumchloride 370 µg/ml; magnesiumchloridehexahydraat 300 µg/ml; natriumgluconaat 5,02 mg/ml; natriumchloride 5,26 mg/ml - oplossing voor infusie - magnesiumchloridehexahydraat 300 µg/ml; kaliumchloride 370 µg/ml; natriumacetaattrihydraat; natriumgluconaat 5.02 mg/ml; natriumchloride 5.26 mg/ml - electrolytes
plasmalyte 148 + glucose 5 % w/v viaflo inf. opl. i.v.
baxter sa-nv - natriumacetaattrihydraat 3,68 g/l; kaliumchloride 370 µg/ml; magnesiumchloridehexahydraat 300 µg/ml; natriumgluconaat 5,02 mg/ml; natriumchloride 5,26 mg/ml; glucosemonohydraat 55 mg/ml - oplossing voor infusie - electrolytes with carbohydrates
plasmalyte 148 + glucose 5 % w/v viaflo inf. opl. i.v.
baxter sa-nv - natriumacetaattrihydraat 3,68 g/l; kaliumchloride 370 µg/ml; magnesiumchloridehexahydraat 300 µg/ml; natriumgluconaat 5,02 mg/ml; natriumchloride 5,26 mg/ml; glucosemonohydraat 55 mg/ml - oplossing voor infusie - electrolytes with carbohydrates
plasmalyte a viaflo inf. opl. i.v.
baxter sa-nv - natriumacetaattrihydraat 3,68 g/l; kaliumchloride 370 µg/ml; magnesiumchloridehexahydraat 300 µg/ml; natriumgluconaat 5,02 mg/ml; natriumchloride 5,26 mg/ml - oplossing voor infusie - electrolytes
plasma-lyte 148, oplossing voor infusie
baxter b.v. kobaltweg 49 3542 ce utrecht - kaliumchloride 0,37 g/l ; magnesiumchloride 6-water (e 511) 0,3 g/l ; natriumacetaat 3-water (e 262) 3,68 g/l ; natriumchloride 5,26 g/l ; natriumgluconaat (e 576) 5,02 g/l ; samenstelling overeenkomend met acetaat (c2h3o2)- 27 mmol/l ; chloride (cl-) 98 mmol/l ; gluconaat (c6h1107)- 23 mmol/l ; kalium (k+) 5 mmol/l ; magnesium (mg2+) 1,5 mmol/l ; natrium (na+) 140 mmol/l - oplossing voor infusie - natriumhydroxide (e 524) ; water voor injectie, - electrolytes
omniplasma 45-70 mg/ml oplossing voor infusie
octapharma gmbh elisabeth-selbert-str. 11 40764 langenfeld (duitsland) - plasma, humaan 45 - 70 mg/ml - oplossing voor infusie - glycine (e 640) ; natriumdiwaterstoffosfaat 2-water (e 339) ; trinatriumcitraat 2-water (e 331), - blood plasma